Evidence map›Paper›PMID 39347541›Full record

ArticleJournal of ophthalmology2024

Novel Human Induced Pluripotent Stem Cell-Based Model for Retinal Pigment Epithelial Cells to Reveal Possible Disease Mechanisms for Macular Degeneration in Pseudoxanthoma Elasticum.

Taina Viheriälä, Heidi Hongisto, Lyydia Saari, Marika Oksanen, Tanja Ilmarinen, Suvi Väärämäki, Hannu Uusitalo, Pasi Nevalainen, Heli Skottman

Abstract read
In one paragraph

Article in Journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Taina ViheriäläFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0009-0007-1082-6657
Heidi HongistoFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0002-2416-5673
Lyydia SaariFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.
Marika OksanenFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0003-4140-4282
Tanja IlmarinenFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0002-4609-8897
Suvi VäärämäkiCentre for Vascular Surgery and Interventional Radiology Tampere University Hospital and Tampere University, Tampere, Finland.
Hannu UusitaloSILK Department of Ophthalmology Faculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0002-8499-8175
Pasi NevalainenDepartment of Internal Medicine Tampere University Hospital, Tampere, Finland.ORCID https://orcid.org/0000-0002-7397-6122
Heli SkottmanFaculty of Medicine and Health Technology Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0002-4127-8792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudoxanthoma elasticum (PXE) is a rare metabolic disease with autosomal recessive inheritance. The manifestation in PXE is represented by retinal complications, pseudoxanthomas of the skin folding areas, and arterial calcification. The retinal complications are caused by the calcification of Bruch's membrane beneath retinal pigment epithelial cells (RPE) that can lead to retinal macular degeneration. The exact mechanism for the retinal pathophysiology is not known, and patients have variable symptoms and findings. Two induced pluripotent stem cell (hiPSC) lines from a patient carrying the common homozygous mutation c.3421C > T, p.Arg1141X in the ATP-binding cassette transporter gene (

Identifiers

PMID39347541
PMCPMC11438508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.